Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 234.

Mortezavi, Ashkan; Krauter, Johanna; Gu, Dr Alexander; Sonderer, Julian; Bruhin, Julia; Reeve, Kelly A; Held, Leonhard; Donati, Olivio F; Rupp, Niels J; Moch, Holger; Sulser, Tullio; Eberli, Daniel (2019). Extensive histological sampling following focal therapy of clinically significant prostate cancer with high-intensity focused ultrasound. Journal of Urology:Epub ahead of print.

Morand, Grégoire B; Ikenberg, Kristian; Vital, Domenic G; Cardona, Isabel; Moch, Holger; Stoeckli, Sandro J; Huber, Gerhard F (2019). Preoperative assessment of CD44-mediated depth of invasion as predictor of occult metastases in early oral squamous cell carcinoma. Head and Neck, 41(4):950-958.

Batavia, Aashil A; Schraml, Peter; Moch, Holger (2019). Clear cell renal cell carcinoma with wild-type von Hippel-Lindau gene: a non-existent or new tumour entity? Histopathology, 74(1):60-67.

Rulle, Undine; Tsourti, Zoi; Casanova, Ruben; Deml, Karl-Friedrich; Verbeken, Eric; Thunnissen, Erik; Warth, Arne; Cheney, Richard; Sejda, Aleksandra; Speel, Ernst Jan; Madsen, Line Bille; Nonaka, Daisuke; Navarro, Atilio; Sansano, Irene; Marchetti, Antonio; Finn, Stephen P; Monkhorst, Kim; Kerr, Keith M; Haberecker, Martina; Wu, Chengguang; Zygoura, Panagiota; Kammler, Roswitha; Geiger, Thomas; Gendreau, Steven; Schulze, Katja; Vrugt, Bart; Wild, Peter; Moch, Holger; Weder, Walter; Ciftlik, Ata Tuna; Dafni, Urania; Peters, Solange; Bubendorf, Lukas; Stahel, Rolf; Soltermann, Alex (2018). Computer-based intensity measurement assists pathologists in scoring PTEN immunohistochemistry - Clinical associations in NSCLC patients of the ETOP Lungscape cohort. Journal of Thoracic Oncology, 13(12):1851-1863.

Rindi, Guido; Klimstra, David S; et al; Moch, Holger (2018). A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Modern Pathology, 31(12):1770-1786.

Banz, Yara; Berezowska, Sabina; de Leval, Laurence; Rubbia-Brandt, Laura; Tolnay, Markus; Moch, Holger; Perren, Aurel; Hewer, Ekkehard (2018). Advancing synoptic cancer reports beyond English: the University of Bern/PathoLink approach. Virchows Archiv, 473(5):655-656.

Velagapudi, Srividya; Schraml, Peter; Yalcinkaya, Mustafa; Bolck, Hella Anna; Rohrer, Lucia; Moch, Holger; von Eckardstein, Arnold (2018). Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma. Journal of Lipid Research, 59(11):2188-2201.

Galimberti, Viviana; Cole, Bernard F; Viale, Giuseppe; Veronesi, Paolo; Vicini, Elisa; Intra, Mattia; et al; Varga, Zsuzsanna; Moch, Holger (2018). Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncology, 19(10):1385-1393.

Binder, Carmen; Matthes, Katarina Luise; Korol, Dimitri; Rohrmann, Sabine; Moch, Holger (2018). Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling. Cancer Medicine, 7(9):4814-4824.

Williamson, Sean R; Rao, Priya; Hes, Ondrej; Epstein, Jonathan I; Smith, Steven C; et al; Moch, Holger (2018). Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists. American Journal of Surgical Pathology, 42(9):1253-1261.

Zhong, Qing; Wagner, Ulrich; Kurt, Henriette; Molinari, Francesca; Cathomas, Gieri; Komminoth, Paul; Barman-Aksözen, Jasmin; Schneider-Yin, Xiaoye; Rey, Jean-Philippe; Vassella, Erik; Rogel, Uwe; Diebold, Joachim; McKee, Thomas; Jochum, Wolfram; Kashofer, Karl; Hofman, Paul; Zischka, Melanie; Moch, Holger; Rechsteiner, Markus; Wild, Peter J (2018). Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing. Pathology, Research and Practice, 214(7):957-963.

Vital, Domenic; Ikenberg, Kristian; Moch, Holger; Roessle, Matthias; Huber, Gerhard F (2018). The expression of the cancer testis antigen MAGE A4: A favorable prognostic biomarker in salivary gland carcinomas related to low tumor grading. Laryngoscope Investigative Otolaryngology, 3(3):182-190.

Tuma, Jan; Moch, Holger; Stuckmann, Gerd; Gysel, Walter; Serra, Andreas L (2018). Two in One: Epithelioid angiomyolipoma within a classic kidney angiomyolipoma - a case report. BMC Nephrology, 19(1):123.

Roswall, Pernilla; Bocci, Matteo; Bartoschek, Michael; et al; Moch, Holger (2018). Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling. Nature Medicine, 24(4):463-473.

Moch, Holger; Ohashi, Riuko; Gandhi, Jatin S; Amin, Mahul B (2018). Morphological clues to the appropriate recognition of hereditary renal neoplasms. Seminars in Diagnostic Pathology, 35(3):184-192.

Keller, Nadia; Andreoni, Federica; Reiber, Claudine; Luethi-Schaller, Helga; Schuepbach, Reto Andreas; Moch, Holger; Maggio, Ewerton Marques; Zinkernagel, Annelies Sophie (2018). Human Streptococcal Necrotizing Fasciitis Histopathology Mirrored in a Murine Model. American Journal of Pathology, 188(7):1517-1523.

Velizheva, Nadezda P; Rechsteiner, Markus P; Valtcheva, Nadejda; Freiberger, Sandra N; Wong, Christine E; Vrugt, Bart; Zhong, Qing; Wagner, Ulrich; Moch, Holger; Hillinger, Sven; Schmitt-Opitz, Isabelle; Soltermann, Alex; Wild, Peter J; Tischler, Verena (2018). Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study. Pathology, Research and Practice, 214(4):572-578.

Fankhauser, Christian D; Schüffler, Peter J; Gillessen, Silke; Omlin, Aurelius; Rupp, Niels J; Rueschoff, Jan H; Hermanns, Thomas; Poyet, Cedric; Sulser, Tullio; Moch, Holger; Wild, Peter J (2018). Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer. OncoTarget, 9(12):10284-10293.

Liu, He; He, Zhaoyue; Bode, Peter; Moch, Holger; Simon, Hans-Uwe (2018). Downregulation of Autophagy-Related Proteins 1, 5, and 16 in Testicular Germ Cell Tumors Parallels Lowered LC3B and Elevated p62 Levels, Suggesting Reduced Basal Autophagy. Frontiers in Oncology, 8:366.

Visentin, Michele; Torozi, Angelo; Gai, Zhibo; Hausler, Stephanie; Li, Chao; Hiller, Christian; Schraml, Peter H; Moch, Holger; Kullak-Ublick, Gerd A (2018). Fluorocholine transport mediated by the organic cation transporter 2 (OCT2,SLC22A2): implication for imaging of kidney tumors. Drug Metabolism and Disposition, 46(8):1129-1136.

Silina, Karina; Soltermann, Alex; Movahedian Attar, Farkhondeh; Casanova, Ruben; Uckeley, Zina M; Thut, Helen; Wandres, Muriel; Isajevs, Sergejs; Cheng, Phil F; Curioni Fontecedro, Alessandra; Foukas, Periklis; Levesque, Mitchell P; Moch, Holger; Linē, Aija; van den Broek, Maries (2018). Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma. Cancer Research, 78(5):1308-1320.

Posch, Florian; Silina, Karina; Leibl, Sebastian; Mündlein, Axel; Moch, Holger; Siebenhüner, Alexander; Samaras, Panagiotis; Riedl, Jakob; Stotz, Michael; Szkandera, Joanna; Stöger, Herbert; Pichler, Martin; Stupp, Roger; van den Broek, Maries; Schraml, Peter; Gerger, Armin; Petrausch, Ulf; Winder, Thomas (2018). Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer. OncoImmunology, 7(2):e1378844.

Singer, Jochen; Ruscheweyh, Hans-Joachim; Hofmann, Ariane L; Thurnherr, Thomas; Singer, Franziska; Toussaint, Nora C; Ng, Charlotte K Y; Piscuoglio, Salvatore; Beisel, Christian; Christofori, Gerhard; Dummer, Reinhard; Hall, Michael N; Krek, Wilhelm; Levesque, Mitchell; Manz, Markus G; Moch, Holger; Papassotiropoulos, Andreas; Stekhoven, Daniel J; Wild, Peter; Wüst, Thomas; Rinn, Bernd; Beerenwinkel, Niko (2018). NGS-pipe: a flexible, easily extendable, and highly configurable framework for NGS analysis. Bioinformatics, 34(1):107-108.

Gut, André; Moch, Holger; Choschzick, Matthias (2018). SOX2 Gene Amplification and Overexpression is Linked to HPV-positive Vulvar Carcinomas. International Journal of Gynecological Pathology, 37(1):68-73.

Rechsteiner, Markus; Dedes, Konstantin; Fink, Daniel; Pestalozzi, Bernhard; Sobottka, Bettina; Moch, Holger; Wild, Peter; Varga, Zsuzsanna (2018). Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological features. Journal of Cancer Research and Clinical Oncology, 144(5):865-874.

101. Jahrestagung der Deutschen Gesellschaft für Pathologie e.V. – Verhandlungen. Edited by: Moch, Holger (2017). Heidelberg: Springer.

Boege, Yannick; Malehmir, Mohsen; Healy, Marc E; Wolf, Monika Julia; Böhm, Friederike; Frick, Lukas; Maire, Renaud; Moch, Holger; Heikenwalder, Mathias; Weber, Achim; Lopes, Massimo; et al (2017). A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development. Cancer Cell, 32(3):342-359.e10.

Rupp, Niels J; Mischo, Axel; Moch, Holger (2017). Neue und vielversprechende molekulare Therapieoptionen in verschiedenen Subtypen des Nierenzellkarzinoms. Therapeutische Umschau. Revue thérapeutique, 74(4):171-179.

Janouskova, Hana; El Tekle, Geniver; Bellini, Elisa; Udeshi, Namrata D; Rinaldi, Anna; Ulbricht, Anna; Bernasocchi, Tiziano; Civenni, Gianluca; Losa, Marco; Svinkina, Tanya; Bielski, Craig M; Kryukov, Gregory V; Cascione, Luciano; Napoli, Sara; Enchev, Radoslav I; Mutch, David G; Carney, Michael E; Berchuck, Andrew; Winterhoff, Boris J N; Broaddus, Russell R; Schraml, Peter; Moch, Holger; Bertoni, Francesco; Catapano, Carlo V; Peter, Matthias; Carr, Steven A; Garraway, Levi A; Wild, Peter J; Theurillat, Jean-Philippe P (2017). Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors. Nature Medicine, 23(9):1046-1054.

Vital, Domenic; Huber, Gerhard F; Holzmann, David; Moch, Holger; Ikenberg, Kristian (2017). The presence of aberrant p53 pattern is a negative prognostic predictor in squamous cell carcinoma of the nasal vestibule. European Archives of Oto-Rhino-Laryngology:3503-3512.

Bogowicz, Marta; Riesterer, Oliver; Ikenberg, Kristian; Stieb, Sonja; Moch, Holger; Studer, Gabriela; Guckenberger, Matthias; Tanadini-Lang, Stephanie (2017). Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma. International Journal of Radiation Oncology, Biology, Physics, 99(4):921-928.

Harlander, Sabine; Schönenberger, Désirée; Toussaint, Nora C; Prummer, Michael; Catalano, Antonella; Brandt, Laura; Moch, Holger; Wild, Peter J; Frew, Ian J (2017). Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice. Nature Medicine, 23(7):869-877.

Ciccarese, Chiara; Montironi, Rodolfo; Fiorentino, Michelangelo; Martignoni, Guido; Brunelli, Matteo; Iacovelli, Roberto; Lopez-Beltran, Antonio; Cheng, Liang; Scarpelli, Marina; Moch, Holger; Tortora, Giampaolo; Massari, Francesco (2017). Circulating Tumor cells: a reliable biomarker for prostate cancer treatment assessment? Current Drug Metabolism, 18(8):692-699.

Blanca, Ana; Cheng, Liang; Montironi, Rodolfo; Moch, Holger; Massari, Francesco; Fiorentino, Michelangelo; Raspollini, Maria Rosaria; Scarpelli, Marina; Lopez-Beltran, Antonio (2017). Mirna expression in bladder cancer and their potential role in clinical practice. Current Drug Metabolism, 18(8):712-722.

Montironi, Rodolfo; Cheng, Liang; Moch, Holger; Lopez-Beltran, Antonio; Scarpelli, Marina; Massari, Francesco; Fiorentino, Michelangelo; Ciccarese, Chiara; Koch, Michael; Kaimakliotis, Hristos Z; Wang, Lisha; Pili, Roberto; Mann, Steven A (2017). Targeting the programmed cell death-1 pathway in genitourinary tumors: current progress and future perspectives. Current Drug Metabolism, 18(8):700-711.

Giunchi, Francesca; Ciccarese, Chiara; Montironi, Rodolfo; Scarpelli, Marina; Lopez-Beltran, Antonio; Cheng, Liang; Moch, Holger; Massari, Francesco; Fiorentino, Michelangelo (2017). Urinary biomarkers for prostate cancer. Current Drug Metabolism, 18(8):723-726.

Chevrier, Stéphane; Levine, Jacob Harrison; Zanotelli, Vito Riccardo Tomaso; Silina, Karina; Schulz, Daniel; Bacac, Marina; Ries, Carola Hermine; Ailles, Laurie; Jewett, Michael Alexander Spencer; Moch, Holger; van den Broek, Maries; Beisel, Christian; Stadler, Michael Beda; Gedye, Craig; Reis, Bernhard; Pe'er, Dana; Bodenmiller, Bernd (2017). An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell, 169(4):736-749.e18.

Corrò, Claudia; Hejhal, Tomas; Poyet, Cédric; Sulser, Tullio; Hermanns, Thomas; Winder, Thomas; Prager, Gerald; Wild, Peter J; Frew, Ian; Moch, Holger; Rechsteiner, Markus (2017). Detecting circulating tumor DNA in renal cancer: An open challenge. Experimental and Molecular Pathology, 102(2):255-261.

Casanova, Ruben; Xia, Daniel; Rulle, Undīne; Nanni, Paolo; Grossmann, Jonas; Vrugt, Bart; Wettstein, Reto; Ballester, Rafael; Astolfo, Alberto; Weder, Walter; Moch, Holger; Stampanoni, Marco; Beck, Andrew H; Soltermann, Alex (2017). Morphoproteomic characterization of lung squamous cell carcinoma fragmentation, a histological marker of increased tumor invasiveness. Cancer Research, 77(10):2585-2593.

Vital, Domenic; Holzmann, David; Huber, Gerhard F; Soyka, Michael B; Moch, Holger; Zimmermann, Dieter R; Ikenberg, Kristian (2017). p16(INK4a) : A surrogate marker of high-risk human papillomavirus infection in squamous cell carcinoma of the nasal vestibule. Head and Neck, 39(7):1392-1398.

Zhong, Qing; Guo, Tiannan; Rechsteiner, Markus; Rüschoff, Jan H; Rupp, Niels; Fankhauser, Christian; Saba, Karim; Mortezavi, Ashkan; Poyet, Cédric; Hermanns, Thomas; Zhu, Yi; Moch, Holger; Aebersold, Ruedi; Wild, Peter J (2017). A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients. Scientific Data, 4:170014.

Williamson, Sean R; Gadde, Ramya; Trpkov, Kiril; Hirsch, Michelle S; Srigley, John R; Reuter, Victor E; Cheng, Liang; Priya Kunju, L; Barod, Ravi; Rogers, Craig G; Delahunt, Brett; Hes, Ondrej; Eble, John N; Zhou, Ming; McKenney, Jesse K; Martignoni, Guido; Fleming, Stewart; Grignon, David J; Moch, Holger; Gupta, Nilesh S (2017). Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists. Human Pathology, 63:150-156.

Mortezavi, Ashkan; Salemi, Souzan; Rupp, Niels J; Rüschoff, Jan Hendrik; Hermanns, Thomas; Poyet, Cedric; Randazzo, Marco; Simon, Hans-Uwe; Moch, Holger; Sulser, Tullio; Wild, Peter; Eberli, Daniel (2017). Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death. OncoTarget, 8(19):31765-31774.

Noske, Aurelia; Brandt, Simone; Valtcheva, Nadejda; Wagner, Ulrich; Zhong, Qing; Bellini, Elisa; Fink, Daniel; Obermann, Ellen C; Moch, Holger; Wild, Peter J (2017). Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer. OncoTarget, 8(9):14794-14805.

Wang, Hui; Schaefer, Thorsten; Konantz, Martina; Braun, Martin; Varga, Zsuzsanna; Paczulla, Anna M; Reich, Selina; Jacob, Francis; Perner, Sven; Moch, Holger; Fehm, Tanja; Kanz, Lothar; Schulze-Osthoff, Klaus; Lengerke, Claudia (2017). Prominent oncogenic roles of EVI1 in breast carcinoma. Cancer Research, 77(8):2148-2160.

Razafinjatovo, Caroline Fanja; Stiehl, Daniel; Deininger, Eva; Rechsteiner, Markus; Moch, Holger; Schraml, Peter (2017). VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma. OncoTarget, 8(6):10199-10212.

Valtcheva, Nadejda; Lang, Franziska M; Noske, Aurelia; Samartzis, Eleftherios P; Schmidt, Anna-Maria; Bellini, Elisa; Fink, Daniel; Moch, Holger; Rechsteiner, Markus; Dedes, Konstantin J; Wild, Peter J (2017). Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report. BMC Cancer, 17(1):1-9.

Wettstein, Marian S; Saba, Karim; Umbehr, Martin H; Murtola, Teemu J; Fankhauser, Christian D; Adank, Jean-Pascal; Hofmann, Marc; Sulser, Tullio; Hermanns, Thomas; Moch, Holger; Wild, Peter; Poyet, Cédric (2017). Prognostic role of preoperative serum lipid levels in patients undergoing radical prostatectomy for clinically localized prostate cancer. The Prostate, 77(5):549-556.

Hofmann, Ariane L; Behr, Jonas; Singer, Jochen; Kuipers, Jack; Beisel, Christian; Schraml, Peter; Moch, Holger; Beerenwinkel, Niko (2017). Detailed simulation of cancer exome sequencing data reveals differences and common limitations of variant callers. BMC Bioinformatics, 18(1):8.

Brandt, Simone; Samartzis, Eleftherios P; Zimmermann, Anne-Kathrin; Fink, Daniel; Moch, Holger; Noske, Aurelia; Dedes, Konstantin J. (2017). Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer. BMC Cancer, 17:44.

Velizheva, Nadezda P; Rechsteiner, Markus P; Wong, Christine E; Zhong, Qing; Rössle, Matthias; Bode, Beata; Moch, Holger; Soltermann, Alex; Wild, Peter J; Tischler, Verena (2017). Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung. Cancer Cytopathology, 125(1):30-40.

Widmann, Raphael; Caduff, Rosmarie; Giudici, Luca; Zhong, Qing; Vogetseder, Alexander; Arlettaz, Romaine; Frey, Bernhard; Moch, Holger; Bode, Peter K (2017). Value of postmortem studies in deceased neonatal and pediatric intensive care unit patients. Virchows Archiv, 470(2):217-223.

Lukamowicz-Rajska, Magdalena; Mittmann, Christiane; Prummer, Michael; Zhong, Qing; Bedke, Jens; Hennenlotter, Jörg; Stenzl, Arnulf; Mischo, Axel; Bihr, Svenja; Schmidinger, Manuela; Vogl, Ursula; Blume, Iris; Karlo, Christoph; Schraml, Peter; Moch, Holger (2016). MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients. OncoTarget:15.

Verhandlungsband zur 100. Jahrestagung der Deutschen Gesellschaft für Pathologie e.V. Edited by: Moch, Holger (2016). Berlin Heidelberg: Springer.

Ruf, Melanie; Moch, Holger; Schraml, Peter (2016). PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma. International Journal of Cancer, 139(2):396-403.

Gramatzki, Dorothee; Frei, Karl; Cathomas, Gieri; Moch, Holger; Weller, Michael; Mertz, Kirsten Diana (2016). Interleukin-33 in human gliomas: Expression and prognostic significance. Oncology Letters, 12(1):445-452.

Sobottka, Bettina; Pestalozzi, Bernhard; Fink, Daniel; Moch, Holger; Varga, Zsuzsanna (2016). Similar lymphocytic infiltration pattern in primary breast cancer and their corresponding distant metastases. OncoImmunology, 5(6):e1153208.

Fankhauser, Christian D; Bode, Peter K; Hermanns, Thomas; Sander, Sophia; Beyer, Joerg; Sulser, Tullio; Altevogt, Peter; Moch, Holger; Tischler, Verena (2016). L1-CAM is commonly expressed in testicular germ cell tumours. Journal of Clinical Pathology, 69(5):460-462.

Humphrey, Peter A; Moch, Holger; Cubilla, Antonio L; Ulbright, Thomas M; Reuter, Victor E (2016). The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours. European Urology:1-14.

Mortezavi, Ashkan; Keller, Etienne Xavier; Poyet, Cédric; Hermanns, Thomas; Saba, Karim; Randazzo, Marco; Fankhauser, Christian Daniel; Wild, Peter J; Moch, Holger; Sulser, Tullio; Eberli, Daniel (2016). Clinical impact of prostate biopsy undergrading in an academic and community setting. World Journal of Urology, 34(10):1481-1490.

Bruder, Elisabeth; Moch, Holger (2016). Das Translokationskarzinom : ein kindlicher NIerentumor auch bei Erwachsenen. Der Pathologe, 37(2):159-165.

Bode, Peter K; Moch, Holger (2016). Nephroblastome : Praktisch immer in Studien! Der Pathologe, 37(2):166-171.

Rohr, Ulrich-Peter; Binder, Carmen; Dieterle, Thomas; Giusti, Francesco; Messina, Carlo Guiseppe Mario; Toerien, Eduard; Moch, Holger; Schäfer, Hans Hendrik (2016). The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report. PLoS ONE, 11(3):e01498.

Moch, Holger (2016). WHO-Klassifikation von 2016 und erste S3-Leitlinie zum Nierenzellkarzinom. Was ist wichtig für die Praxis. Der Pathologe, 37(2):127-133.

Moch, Holger; Cubilla, Antonio L; Humphrey, Peter A; Reuter, Victor E; Ulbright, Thomas M (2016). The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. European Urology:1-13.

Rössle, Matthias; Cathomas, Gieri; Bonapace, Laura; Sachs, Melanie; Dehler, Silvia; Storz, Martina; Huber, Gerhard; Moch, Holger; Junt, Tobias; Mertz, Kirsten D (2016). Interleukin-33 expression indicates a favorable prognosis in malignant salivary gland tumors. International journal of surgical pathology, 24(5):394-400.

Weller, Michael; Nabors, Louis Burt; Gorlia, Thierry; Leske, Henning; Rushing, Elisabeth; Bady, Pierre; Hicking, Christine; Perry, James; Hong, Yong-Kil; Roth, Patrick; Wick, Wolfgang; Goodman, Simon L; Hegi, Monika E; Picard, Martin; Moch, Holger; Straub, Josef; Stupp, Roger (2016). Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome. OncoTarget, 7(12):15018-15032.

Schneider, Daniel; Riegman, Peter H J; Cronin, Maureen; Negrouk, Anastassia; Moch, Holger; Balling, Rudi; Penault-Llorca, Frederiques; Zatloukal, Kurt; Horgan, Denis (2016). Accelerating the Development and Validation of New Value-Based Diagnostics by Leveraging Biobanks. Public Health Genomics, 19(3):160-169.

Razafinjatovo, Caroline; Bihr, Svenja; Mischo, Axel; Vogl, Ursula; Schmidinger, Manuela; Moch, Holger; Schraml, Peter (2016). Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance. BMC Cancer, 16:638.

Gugger, Alenka; Barnhill, Raymond L; Seifert, Burkhardt; Dehler, Silvia; Moch, Holger; Lugassy, Claire; Marques-Maggio, Ewerton; Rushing, Elisabeth J; Mihic-Probst, Daniela (2016). Cutaneous melanoma with brain metastasis: Report of 193 patients with new observations. PLoS ONE, 11(5):e0156115.

Beleut, Manfred; Soeldner, Robert; Egorov, Mark; Guenther, Rolf; Dehler, Silvia; Morys-Wortmann, Corinna; Moch, Holger; Henco, Karsten; Schraml, Peter (2016). Discretization of Gene Expression Data Unmasks Molecular Subgroups Recurring in Different Human Cancer Types. PLoS ONE, 11(8):e0161514.

Montironi, Rodolfo; Santoni, Matteo; Sotte, Valeria; Cheng, Liang; Lopez-Beltran, Antonio; Massari, Francesco; Matrana, Marc R; Moch, Holger; Berardi, Rossana; Scarpelli, Marina (2016). Emerging immunotargets and immunotherapies in prostate cancer. Current Drug Targets, 17(7):777-782.

Stoehr, Christine G; Stoehr, Robert; Wenners, Antonia; Hartmann, Arndt; Bertz, Simone; Spath, Verena; Walter, Bernhard; Junker, Kerstin; Moch, Holger; Hinze, Raoul; Denzinger, Stefan; Bond, Elisabeth E; Bond, Gareth L; Bluemke, Karen; Weigelt, Katrin; Lieb, Verena; Nolte, Elke; Fornara, Paolo; Wullich, Bernd; Taubert, Helge; Wach, Sven (2016). Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients. Oncogenesis, 5(e205):1-5.

Schödel, Johannes; Grampp, Steffen; Maher, Eamonn R; Moch, Holger; Ratcliffe, Peter J; Russo, Paul; Mole, David R (2016). Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer. European Urology, 69(4):646-657.

Zhong, Qing; Rüschoff, Jan H; Guo, Tiannan; Gabrani, Maria; Schüffler, Peter J; Rechsteiner, Markus; Liu, Yansheng; Fuchs, Thomas J; Rupp, Niels J; Fankhauser, Christian; Buhmann, Joachim M; Perner, Sven; Poyet, Cédric; Blattner, Miriam; Soldini, Davide; Moch, Holger; Rubin, Mark A; Noske, Aurelia; Rüschoff, Josef; Haffner, Michael C; Jochum, Wolfram; Wild, Peter J (2016). Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity. Scientific Reports, 6:24146.

Störkel, Stephan; Wild, Peter J; Moch, Holger (2016). Nierentumoren im Erwachsenenalter. In: Amann, Kerstin; Kain, Renate; Klöppel, Günter. Pathologie. Berlin Heidelberg: Springer, 443-485.

Rupp, Niels J; Schüffler, Peter J; Zhong, Qing; Falkner, Florian; Rechsteiner, Markus; Rüschoff, Jan H; Fankhauser, Christian; Drach, Matthias; Largo, Remo; Tremp, Mathias; Poyet, Cedric; Sulser, Tullio; Kristiansen, Glen; Moch, Holger; Buhmann, Joachim; Müntener, Michael; Wild, Peter J (2016). Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer. Journal of Pathology Informatics, 7:3.

Mertz, Kirsten D; Mager, Lukas F; Wasmer, Marie-Hélène; Thiesler, Thore; Koelzer, Viktor H; Ruzzante, Giulia; Joller, Stefanie; Murdoch, Jenna R; Brümmendorf, Thomas; Genitsch, Vera; Lugli, Alessandro; Cathomas, Gieri; Moch, Holger; Weber, Achim; Zlobec, Inti; Junt, Tobias; Krebs, Philippe (2016). The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice. OncoImmunology, 5(1):e1062966.

Stoehr, Christine G; Walter, Bernhard; Denzinger, Stefan; Ghiorzo, Paola; Sturm, Richard A; Hinze, Raoul; Moch, Holger; Junker, Kerstin; Hartmann, Arndt; Stoehr, Robert (2016). The microphthalmia-associated transcription factor p.E318K mutation does not play a major role in sporadic renal cell tumors from caucasian patients. Pathobiology, 83(4):165-169.

WHO classification of tumours of the urinary system and male genital organs. Edited by: Moch, Holger; Humphrey, Peter A; Ulbright, Thomas M; Reuter, Victor E (2016). Lyon: International Agency for Research on Cancer (IARC).

Montironi, Rodolfo; Santoni, Matteo; Cheng, Liang; Lopez-Beltran, Antonio; Massari, Francesco; Matrana, Marc R; Moch, Holger; Scarpelli, Marina (2015). An overview of emerging immunotargets of genitourinary tumors. Current Drug Targets, 17:1.

Ruf, Melanie; Moch, Holger; Schraml, Peter (2015). Interaction of tumor cells with infiltrating lymphocytes via CD70 and CD27 in clear cell renal cell carcinoma. OncoImmunology, 4(12):e1049805.

Poyet, Cédric; Buser, Lorenz; Roudnicky, Filip; Detmar, Michael; Hermanns, Thomas; Mannhard, Doris; Höhn, Andrej; Rüschoff, Jan; Zhong, Qing; Sulser, Tullio; Moch, Holger; Wild, Peter J (2015). Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer. Journal of Clinical Pathology:online.

Hofmann, Andreas; Thiesler, Thore; Gerrits, Bertran; Behnke, Silvia; Sobotzki, Nadine; Omasits, Ulrich; Bausch-Fluck, Damaris; Bock, Thomas; Aebersold, Ruedi; Moch, Holger; Tinguely, Marianne; Wollscheid, Bernd (2015). Surfaceome of classical Hodgkin and non-Hodgkin lymphoma. Proteomics. Clinical applications, 9(7-8):661-670.

Bieri, Uwe; Moch, Holger; Dehler, Silvia; Korol, Dimitri; Rohrmann, Sabine (2015). Changes in autopsy rates among cancer patients and their impact on cancer statistics from a public health point of view: a longitudinal study from 1980 to 2010 with data from Cancer Registry Zurich. Virchows Archiv, 466(6):637-643.

Winklhofer, Sebastian; Peter, Silvia; Tischler, Verena; Morsbach, Fabian; von Werdt, Moritz; Berens, Sandra; Modregger, Peter; Buser, Lorenz; Moch, Holger; Stampanoni, Marco; Thali, Michael; Alkadhi, Hatem; Stolzmann, Paul (2015). Diagnostic accuracy of quantitative and qualitative phase-contrast imaging for the ex vivo characterization of human coronary atherosclerotic plaques. Radiology, 277(1):64-72.

Fankhauser, Christian D; Sulser, Tullio; Zhong, Qing; Barghorn, André; Moch, Holger; Bode, Peter K (2015). CD10 expression in 325 testicular germ cell tumours. Journal of Clinical Pathology, 68(5):400-403.

Moch, Holger (2015). Neuroendokrine Tumoren der Niere. Der Pathologe, 36(3):278-282.

Dettmer, Matthias S; Schmitt, Anja Maria; Steinert, Hans; Capper, David; Moch, Holger; Komminoth, Paul; Perren, Aurel (2015). Tall cell Papillary Thyroid Carcinoma: new diagnostic criteria and mutations in BRAF and TERT. Endocrine-Related Cancer, 22(3):419-429.

Fluri, Felix; Grünstein, Dan; Cam, Ertugrul; Ungethuem, Udo; Hatz, Florian; Schäfer, Juliane; Samnick, Samuel; Israel, Ina; Kleinschnitz, Christoph; Orts-Gil, Guillermo; Moch, Holger; Zeis, Thomas; Schaeren-Wiemers, Nicole; Seeberger, Peter (2015). Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats. Experimental Neurology, 265:142-151.

Ruf, Melanie; Mittmann, Christiane; Nowicka, Anna M; Hartmann, Arndt; Hermanns, Thomas; Poyet, Cédric; van den Broek, Maries; Sulser, Tullio; Moch, Holger; Schraml, Peter (2015). pVHL/HIF-regulated CD70 expression is associated with infiltration of CD27+ lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma. Clinical Cancer Research, 21(4):889-98.

Frischknecht, Lukas; Meerang, Mayura; Soltermann, Alex; Stahel, Rolf; Moch, Holger; Seifert, Burkhardt; Weder, Walter; Opitz, Isabelle (2015). Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery. Journal of Thoracic and Cardiovascular Surgery, 149(6):1539-1547.e1.

Shakhova, Olga; Cheng, Phil; Mishra, Pravin J; Zingg, Daniel; Schaefer, Simon M; Debbache, Julien; Häusel, Jessica; Matter, Claudia; Guo, Theresa; Davis, Sean; Meltzer, Paul; Mihic-Probst, Daniela; Moch, Holger; Wegner, Michael; Merlino, Glenn; Levesque, Mitchell P; Dummer, Reinhard; Santoro, Raffaella; Cinelli, Paolo; Sommer, Lukas (2015). Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma. PLoS Genetics, 11(1):e1004877.

Frew, Ian J; Moch, Holger (2015). A clearer view of the molecular complexity of clear cell renal cell carcinoma. Annual Review of Pathology, 10(1):263-289.

Mangana, Joanna; Cheng, Phil F; Schindler, Katja; Weide, Benjamin; Held, Ulrike; Frauchiger, Anna L; Romano, Emanuella; Kähler, Katharina C; Rozati, Sima; Rechsteiner, Markus; Moch, Holger; Michielin, Olivier; Garbe, Claus; Hauschild, Axel; Hoeller, Christoph; Dummer, Reinhard; Goldinger, Simone M (2015). Analysis of BRAF and NRAS mutation status in advanced melanoma patients treated with anti-CTLA-4 antibodies: association with overall survival? PLoS ONE, 10(10):e0139438.

Lopez-Beltran, Antonio; Santoni, Matteo; Massari, Francesco; Ciccarese, Chiara; Tortora, Giampaolo; Cheng, Liang; Moch, Holger; Scarpelli, Marina; Reymundo, Carlos; Montironi, Rodolfo (2015). Bladder cancer: molecular determinants of personalized therapy. Current Drug Targets, 16(2):115-124.

Curioni-Fontecedro, Alessandra; Martin, Vittoria; Vogetseder, Alexander; Knuth, Alexander; Moch, Holger; Soldini, Davide; Tinguely, Marianne (2015). Chromosomal aberrations of cancer-testis antigens in myeloma patients. Hematological oncology, 33(3):159-163.

Pflueger, Dorothee; Mittmann, Christiane; Dehler, Silvia; Rubin, Mark A; Moch, Holger; Schraml, Peter (2015). Functional characterization of BC039389-GATM and KLK4-KRSP1 chimeric read-through transcripts which are up-regulated in renal cell cancer. BMC Genomics, 16(247):online.

Eppler, Elisabeth; Janas, Eva; Link, Karl; Weidmann, Lukas; Bischofberger, Helena; Wenger, Michael; Tinguely, Marianne; Schraml, Peter; Moch, Holger; Fellbaum, Christian (2015). Insulin-like growth factor I is expressed in classical and nodular lymphocyte-predominant Hodgkin's lymphoma tumour and microenvironmental cells. Cell and Tissue Research, 359(3):841-851.

Friemel, Juliane; Rechsteiner, Markus Peter; Frick, Lukas; Boehm, Friederike; Struckmann, Kirsten; Sigg, Michele; Moch, Holger; Heikenwaelder, Mathias; Weber, Achim (2015). Intratumor heterogeneity in hepatocellular carcinoma. Clinical Cancer Research, 21(8):1951-1961.

Mosquera, Juan-Miguel; Varma, Sonal; Pauli, Chantal; MacDonald, Theresa Y; Yashinskie, Jossie J; Varga, Zsuzsanna; Sboner, Andrea; Moch, Holger; Rubin, Mark A; Shin, Sandra J (2015). MAGI3–AKT3 fusion in breast cancer amended. Nature, 520(7547):E11-E12.

Fisher, Kurt W; Montironi, Rodolfo; Lopez Beltran, Antonio; Moch, Holger; Wang, Lisha; Scarpelli, Marina; Williamson, Sean R; Koch, Michael O; Cheng, Liang (2015). Molecular foundations for personalized therapy in prostate cancer. Current Drug Targets, 16(2):103-114.

Moch, Holger; Montironi, Rodolfo; Lopez-Beltran, Antonio; Cheng, Liang; Mischo, Axel (2015). Oncotargets in different renal cancer subtypes. Current Drug Targets, 16(2):125-135.

Noske, Aurelia; Henricksen, Leigh A; LaFleur, Bonnie; Zimmermann, Anne-Katrin; Tubbs, Alisa; Singh, Shalini; Storz, Martina; Fink, Daniel; Moch, Holger (2014). Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes. Experimental and Molecular Pathology, 98(1):47-54.

Montironi, Rodolfo; Santoni, Matteo; Lopez-Beltran, Antonio; Cheng, Liang; Moch, Holger; Scarpelli, Marina (2014). Morphologic and molecular backgrounds for personalized management of genito-urinary cancers: an Overview. Current Drug Targets, 16(2):96-102.

Rioux-Leclercq, Nathalie; Ferran, Algaba; Mahul, Amin; Argani, Pedram; Billis, Athanase; Bonsib, Stephen; Cheng, Liang; Cheville, John; Eble, John; Egevad, Lars; Epstein, Jonathan; Grignon, David; Hes, Ondrej; Humphrey, Peter; Magi-Galluzzi, Cristina; Martignoni, Guido; McKenney, Jesse; Merino, Maria; Moch, Holger; Montironi, Rodolfo; Netto, George; Reuter, Viktor; Samaratunga, Hemamali; Shen, Steven; Srigley, John; Tamboli, Pheroze; Tan, Puay Hoon; Tickoo, Satish; Trpkov, Kiril; Zhou, Ming; Delahunt, Brett; Comperat, Eva (2014). Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations. Annales de Pathologie, 34(6):448-461.

Walter, Katharina M; Schönenberger, Miriam J; Trötzmüller, Martin; Horn, Michael; Elsässer, Hans-Peter; Moser, Ann B; Lucas, Miriam S; Schwarz, Tobias; Gerber, Philipp A; Faust, Phyllis L; Moch, Holger; Köfeler, Harald C; Krek, Wilhelm; Kovacs, Werner J (2014). Hif-2α promotes degradation of Mammalian peroxisomes by selective autophagy. Cell Metabolism, 20(5):882-897.

Wang, Yihua; Bu, Fangfang; Royer, Christophe; Serres, Sébastien; Larkin, James R; Soto, Manuel Sarmiento; Sibson, Nicola R; Salter, Victoria; Fritzsche, Florian; Turnquist, Casmir; Koch, Sofia; Zak, Jaroslav; Zhong, Shan; Wu, Guobin; Liang, Anmin; Olofsen, Patricia A; Moch, Holger; Hancock, David C; Downward, Julian; Goldin, Robert D; Zhao, Jian; Tong, Xin; Guo, Yajun; Lu, Xin (2014). ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1. Nature Cell Biology, 16(11):1092-1104.

Fellmann, Jonas; Weisert, Jan U; Soltermann, Alex; Morand, Grégoire; Morra, Laura; Moch, Holger; Huber, Gerhard F; Probst, Rudolf (2014). Helicobacter pylori detected in pharyngeal and laryngeal pathologies in patients with proven gastric colonization. Head and Neck, 36(11):1562-1566.

von Laffert, Maximilian; Warth, Arne; Penzel, Roland; Schirmacher, Peter; Kerr, Keith M; Elmberger, Göran; Schildhaus, Hans-Ulrich; Büttner, Reinhard; Lopez-Rios, Fernando; Reu, Simone; Kirchner, Thomas; Pauwels, Patrick; Specht, Katja; Drecoll, Enken; Höfler, Heinz; Aust, Daniela; Baretton, Gustavo; Bubendorf, Lukas; Stallmann, Sonja; Fisseler-Eckhoff, Annette; Soltermann, Alex; Tischler, Verena; Moch, Holger; Penault-Llorca, Frederique; Hager, Hendrik; Schäper, Frank; Lenze, Dido; Hummel, Michael; Dietel, Manfred (2014). Multicenter Immunohistochemical ALK-Testing of Non-Small-Cell Lung Cancer Shows High Concordance after Harmonization of Techniques and Interpretation Criteria. Journal of Thoracic Oncology, 9(11):1685-1692.

Meller, Sebastian; Bicker, Anne; Montani, Matteo; Ikenberg, Kristian; Rostamzadeh, Babak; Sailer, Verena; Wild, Peter; Dietrich, Dimo; Uhl, Barbara; Sulser, Tullio; Moch, Holger; Gorr, Thomas A; Stephan, Carsten; Jung, Klaus; Hankeln, Thomas; Kristiansen, Glen (2014). Myoglobin expression in prostate cancer is correlated to androgen receptor expression and markers of tumor hypoxia. Virchows Archiv, 465(4):419-427.

Ikenberg, Kristian; Valtcheva, Nadejda; Brandt, Simone; Zhong, Qing; Wong, Christine E; Noske, Aurelia; Rechsteiner, Markus; Rueschoff, Jan H; Caduff, Rosmarie; Dellas, Athanassios; Obermann, Ellen; Fink, Daniel; Fuchs, Thomas; Krek, Wilhelm; Moch, Holger; Frew, Ian J; Wild, Peter J (2014). KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. Journal of Pathology, 234(2):239-252.

Dettmer, Matthias S; Perren, Aurel; Moch, Holger; Komminoth, Paul; Nikiforov, Yuri E; Nikiforova, Marina N (2014). MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights. Journal of Molecular Endocrinology, 52(2):181-189.

Bitanihirwe, Byron K Y; Meerang, Mayura; Friess, Martina; Soltermann, Alex; Frischknecht, Lukas; Thies, Svenja; Felley-Bosco, Emanuela; Tsao, Ming-Sound; Allo, Ghassan; de Perrot, Marc; Seifert, Burkhardt; Moch, Holger; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2014). PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy. Journal of Thoracic Oncology, 9(2):239-247.

98. Jahrestagung der Deutschen Gesellschaft für Pathologie e. V. Edited by: Moch, Holger (2014). Berlin Heidelberg: Springer.

Lenggenhager, Daniela; Curioni-Fontecedro, Alessandra; Storz, Martina; Shakhova, Olga; Sommer, Lukas; Widmer, Daniel S; Seifert, Burkhardt; Moch, Holger; Dummer, Reinhard; Mihic-Probst, Daniela (2014). An aggressive hypoxia related subpopulation of melanoma cells is TRP-2 Negative. Translational Oncology, 7(2):206-212.

Rechsteiner, Markus P; Floros, Xenofon; Boehm, Bernhard O; Marselli, Lorella; Marchetti, Piero; Stoffel, Markus; Moch, Holger; Spinas, Giatgen A (2014). Automated assessment of β-cell area and density per islet and patient using TMEM27 and BACE2 immunofluorescence staining in human pancreatic β-cells. PLoS ONE, 9(6):e98932.

Moch, Holger; Srigley, John; Delahunt, Brett; Montironi, Rodolfo; Egevad, Lars; Tan, Puay Hoon (2014). Biomarkers in renal cancer. Virchows Archiv, 464(3):359-365.

Bode, Peter K; Thielken, Andrea; Brandt, Simone; Barghorn, André; Lohe, Bernd; Knuth, Alexander; Moch, Holger (2014). Cancer testis antigen expression in testicular germ cell tumorigenesis. Modern Pathology, 27(6):899-905.

Amin, Mahul B; Smith, Steven C; Agaimy, Abbas; Argani, Pedram; Compérat, Eva Marie; Delahunt, Brett; Epstein, Jonathan I; Eble, John N; Grignon, David J; Hartmann, Arndt; Hes, Ondřej; Hirsch, Michelle S; Jimenez, Rafael E; Kunju, Lakshmi P; Martignoni, Guido; McKenney, Jesse K; Moch, Holger; Montironi, Rodolfo; Paner, Gladell P; Rao, Priya; Srigley, John R; Tickoo, Satish K; Reuter, Victor E (2014). Collecting duct carcinoma versus renal medullary carcinoma: An appeal for nosologic and biological clarity. American Journal of Surgical Pathology, 38(7):871-874.

Varga, Zsuzsanna; Tubbs, Raymond R; Moch, Holger (2014). Concomitant Detection of HER2 Protein and Gene Alterations by Immunohistochemistry (IHC) and Silver Enhanced In Situ Hybridization (SISH) Identifies HER2 Positive Breast Cancer with and without Gene Amplification. PLoS ONE, 9(8):e105961.

Koppensteiner, Romana; Samartzis, Eleftherios P; Noske, Aurelia; von Teichman, Adriana; Dedes, Ioannis; Gwerder, Myriam; Imesch, Patrick; Ikenberg, Kristian; Moch, Holger; Fink, Daniel; Stucki, Manuel; Dedes, Konstantin J (2014). Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro. PLoS ONE, 9(6):e100041.

Poyet, Cédric; Jentsch, Bastian; Hermanns, Thomas; Schweckendiek, Daniel; Seifert, Hans-Helge; Schmidtpeter, Martin; Sulser, Tullio; Moch, Holger; Wild, Peter J; Kristiansen, Glen (2014). Expression of histone deacetylases 1,2 and 3 in urothelial bladder cancer. BMC Clinical Pathology, 14:10.

Moch, Holger (2014). Kidney Cancer. In: Stewart, B W; Wild, C P. World Cancer report 2014. Lyon: IARC, 2-9.

Bode, Peter K; Cathomas, Gieri; Vogt, Peter; Moch, Holger (2014). Klinische Autopsie. Praxis, 103(2):65-71.

Wolf, Monika Julia; Adili, Arlind; Piotrowitz, Kira; et al; Boege, Yannick; Egger, Michèle; Moch, Holger; Kopf, Manfred; Weber, Achim; Heikenwalder, Mathias (2014). Metabolic activation of intrahepatic CD8(+) T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell, 26(4):549-564.

Rechsteiner, Markus; Müller, Rouven; Reineke, Tanja; Goede, Jeroen; Bohnert, Annette; Zhong, Qing; Manz, Markus G; Moch, Holger; Wild, Peter J; Zimmermann, Dieter R; Tinguely, Marianne (2014). Modelling of a genetically diverse evolution of Systemic Mastocytosis with Chronic Myelomonocytic Leukemia (SM-CMML) by next generation sequencing. Experimental Hematology & Oncology, 3:18.

Theurillat, Jean-Philippe P; Udeshi, Namrata D; Errington, Wesley J; et al; Wild, Peter J; Moch, Holger; Garraway, Levi A (2014). Prostate cancer: Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer. Science, 346(6205):85-89.

Blattner, Mirjam; Lee, Daniel J; O'Reilly, Catherine; Park, Kyung; MacDonald, Theresa Y; Khani, Francesca; Turner, Kevin R; Chiu, Ya-Lin; Wild, Peter J; Dolgalev, Igor; Heguy, Adriana; Sboner, Andrea; Ramazangolu, Sinan; Hieronymus, Haley; Sawyers, Charles; Tewari, Ashutosh K; Moch, Holger; Yoon, Ghil Suk; Known, Yong Chul; Andrén, Ove; Fall, Katja; Demichelis, Francecsa; Mosquera, Juan Miguel; Robinson, Brian D; Barbieri, Christopher E; Rubin, Mark A (2014). SPOP mutations in prostate cancer across demographically diverse patient cohorts. Neoplasia, 16(1):14-20.

Moch, Holger; Lukamowicz-Rajska, Magdalena (2014). miR-30c-2-3p and miR-30a-3p: New pieces of the Jigsaw puzzle in HIF2α regulation. Cancer Discovery, 4(1):22-24.

97. Jahrestagung der Deutschen Gesellschaft für Pathologie e. V. Edited by: Moch, Holger (2013). Berlin Heidelberg: Springer.

Varga, Zsuzsanna; Noske, Aurelia; Ramach, Constanze; Padberg, Barbara; Moch, Holger (2013). Assessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in situ hybridization and immunohistochemistry in a single institution over 12 years: a quality control study. BMC Cancer, 13:615.

Autopsie und Religion: Die Sektion aus medizinischer, ethischer und religiöser Sicht. Edited by: Tag, Brigitte; Mausbach, Julian; Moch, Holger (2013). Weimar: VDG Verlag und Datenbank für Geisteswissenschaften.

Albers, Joachim; Rajski, Michal; Schönenberger, Désirée; Harlander, Sabine; Schraml, Peter; von Teichman, Adriana; Georgiev, Strahil; Wild, Peter J; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2013). Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice. EMBO Molecular Medicine, 5(6):949-964.

Varga, Zsuzsanna; Sinn, Peter; Fritzsche, Florian; von Hochstetter, Arthur; Noske, Aurelia; Schraml, Peter; Tausch, Christoph; Trojan, Andreas; Moch, Holger (2013). Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer. PLoS ONE, 8(3):e58483.

Dettmer, Matthias Stephan; Perren, Aurel; Moch, Holger; Komminoth, Paul; Nikiforov, Yuri E; Nikiforova, Marina N (2013). Comprehensive microRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma. Thyroid, 23(11):1383-1389.

Reiner, Caecilia S; Roessle, Matthias; Thiesler, Thore; Eberli, Daniel; Klotz, Ernst; Frauenfelder, Thomas; Sulser, Tullio; Moch, Holger; Alkadhi, Hatem (2013). Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers. Investigative Radiology, 48(4):183-191.

Varga, Zsuzsanna; Sinn, Peter; Fritzsche, Florian; von Hochstetter, Arthur; Noske, Aurelia; Schraml, Peter; Tausch, Christoph; Trojan, Andreas; Moch, Holger (2013). Correction: Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer. PLoS ONE, 8(10):e58483.

Boos, Laura A; Dettmer, Matthias; Schmitt, Anja; Rudolph, Thomas; Steinert, Hans; Moch, Holger; Sobrinho-Simões, Manuel; Komminoth, Paul; Perren, Aurel (2013). Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases. Histopathology, 63(2):234-241.

Eichelberg, Christian; Chun, Felix K; Bedke, Jens; Heuer, Roman; Adam, Meike; Moch, Holger; Terracciano, Luigi; Hinrichs, Kristin; Dahlem, Roland; Fisch, Margit; Schlomm, Thorsten; Sauter, Guido; Minner, Sarah (2013). Epithelial cell adhesion molecule (EPCAM) is an independent prognostic marker in clear cell renal carcinoma. International journal of cancer. Journal international du cancer, 132(12):2948-2955.

Sanjmyatav, Jimsgene; Hauke, Sven; Gajda, Mieczyslaw; Hartmann, Arndt; Moch, Holger; Meyer, Britta; Pryalukhin, Alexey; Grimm, Marc-Oliver; Junker, Kerstin (2013). Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours. European Urology, 64(4):689-691.

Zimmermann, Anne-Katrin; Imig, Jochen; Klar, Agnes; Renner, Christoph; Korol, Dimitri; Fink, Daniel; Stadlmann, Sylvia; Singer, Gad; Knuth, Alexander; Moch, Holger; Caduff, Rosmarie (2013). Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas. Virchows Archiv, 462(5):565-574.

Lenggenhager, Daniela; Maggio, Ewerton M; Moch, Holger; Rössle, Matthias (2013). HBME-1 expression in hyalinizing trabecular tumours of the thyroid gland. Histopathology, 62(7):1092-1097.

Pflueger, Dorothee; Sboner, Andrea; Storz, Martina; Roth, Jasmine; Compérat, Eva; Bruder, Elisabeth; Rubin, Mark A; Schraml, Peter; Moch, Holger (2013). Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing. Neoplasia, 15(11):1231-1240.

Hell, Michael P; Duda, Maria; Weber, Thomas C; Moch, Holger; Krek, Wilhelm (2013). Ischemic renal injury reveals in vivo functions for the von Hippel-Lindau tumor suppressor in mitotic fidelity control. Cancer Research:1-32.

Rechsteiner, Markus; von Teichman, Adriana; Rüschoff, Jan H; Fankhauser, Niklaus; Pestalozzi, Bernhard; Schraml, Peter; Weber, Achim; Wild, Peter; Zimmermann, Dieter; Moch, Holger (2013). KRAS, BRAF, and TP53 deep-sequencing for colorectal carcinoma patient diagnostics. Journal of Molecular Diagnostics, 15(3):299-311.

Moch, Holger (2013). Klassifikation und molekulare Veränderungen des Nierenzellkarzinoms. Schweizer Zeitschrift für Onkologie, (3):5-9.

Pawłowski, Rafal; Mühl, Sarah M; Sulser, Tullio; Krek, Wilhelm; Moch, Holger; Schraml, Peter (2013). Loss of PBRM1 expression is associated with renal cell carcinoma progression. International Journal of Cancer, 132(2):E11-7.

Perner, Sven; Rupp, Niels J; Braun, Martin; Rubin, Mark A; Moch, Holger; Dietel, Manfred; Wernert, Nicolas; Jung, Klaus; Stephan, Carsten; Kristiansen, Glen (2013). Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course. International Journal of Cancer, 132(4):807-812.

Dettmer, Matthias; Vogetseder, Alexander; Durso, Mary Beth; Moch, Holger; Komminoth, Paul; Perren, Aurel; Nikiforov, Yuri E; Nikiforova, Marina N (2013). MicroRNA Expression Array Identifies Novel Diagnostic Markers for Conventional and Oncocytic Follicular Thyroid Carcinomas. The Journal of clinical endocrinology and metabolism, 98(1):E1-7.

von Boehmer, Lotta; Mattle, Muriel; Bode, Peter; Landshammer, Alexandro; Schäfer, Carolin; Nuber, Natko; Ritter, Gerd; Old, Lloyd; Moch, Holger; Schäfer, Niklaus; Jäger, Elke; Knuth, Alexander; van den Broek, Maries (2013). NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma. Cancer Immunity, 13:12.

Blyszczuk, Przemyslaw; Berthonneche, Corrine; Behnke, Silvia; Glönkler, Marcel; Moch, Holger; Pedrazzini, Thierry; Lüscher, Thomas F; Eriksson, Urs; Kania, Gabriela (2013). Nitric oxide synthase 2 is required for conversion of pro-fibrogenic inflammatory CD133+ progenitors into F4/80+ macrophages in experimental autoimmune myocarditis. Cardiovascular Research, 97(2):219-229.

Wild, Peter J; Zhong, Qing; Zimmermann, Dieter R; Rechsteiner, Markus; Fritz, Christine; Valtcheva, Nadejda; Moch, Holger (2013). Personalisierte Krebsmedizin und die Zukunft der Pathologie. info@onkologie, 6:9-12.

Braun, Martin; Kirsten, Robert; Rupp, Niels J; Moch, Holger; Fend, Falko; Wernert, Nicolas; Kristiansen, Glen; Perner, Sven (2013). Quantification of protein expression in cells and cellular subcompartments on immunohistochemical sections using a computer supported image analysis system. Histology and Histopathology, 28(5):605-610.

Sharma, Anu; Bode, Beata; Moch, Holger; Okoniewski, Michal; Knuth, Alexander; von Boehmer, Lotta; van den Broek, Maries (2013). Radiotherapy of human sarcoma promotes an intratumoral immune effector signature. Clinical Cancer Research, 19(17):4843-4853.

Tan, Puay Hoon; Cheng, Liang; Rioux-Leclercq, Nathalie; Merino, Maria J; Netto, George; Reuter, Victor E; Shen, Steven S; Grignon, David J; Montironi, Rodolfo; Egevad, Lars; Srigley, John R; Delahunt, Brett; Moch, Holger (2013). Renal tumors: Diagnostic and prognostic biomarkers. American Journal of Surgical Pathology, 37(10):1518-1531.

Sanjmyatav, Jimsgene; Hartmann, Arndt; Moch, Holger; Hauke, Sven; Gajda, Mieczyslaw; Meyer, Britta; Pryalukhin, Alexey; Grimm, Marc-Oliver; Junker, Kerstin (2013). Reply to Jérôme Verine, Christophe Leboeuf and Philippe Ratajczak's Letter to the Editor re: Jimsgene Sanjmyatav, Sven Hauke, Mieczyslaw Gajda, et al. Establishment of a Multicolour Fluorescence In Situ Hybridisation-based Assay for Subtyping of Renal Cell Tumours. Eur Urol 2013;64:689-91. European Urology:1.

Zeh, Nina; Wild, Peter J; Bode, Peter K; Kristiansen, Glen; Moch, Holger; Sulser, Tullio; Hermanns, Thomas (2013). Retroperitoneal teratoma with somatic malignant transformation: A papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy. BMC Urology, 13:9.

Deisl, Christine; Simonin, Alexandre; Anderegg, Manuel; Albano, Giuseppe; Kovacs, Gergely; Ackermann, Daniel; Moch, Holger; Dolci, Wanda; Thorens, Bernard; Hediger, Matthias A; Fuster, Daniel G (2013). Sodium/hydrogen exchanger NHA2 is critical for insulin secretion in β-cells. Proceedings of the National Academy of Sciences of the United States of America, 110(24):10004-10009.

Dannenmann, Stefanie R; Hermanns, Thomas; Bransi, Ali; Matter, Claudia; von Boehmer, Lotta; Stevanovic, Stefan; Schraml, Peter; Moch, Holger; Knuth, Alexander; van den Broek, Maries (2013). Spontaneous peripheral T-cell responses toward the tumor-associated antigen cyclin D1 in patients with clear cell renal cell carcinoma. Cancer Immunology Research, 1(5):288-295.

Tag, Brigitte; Moch, Holger (2013). Symposium Autopsie und Religion. In: Hacker, Jörg. Jahrbuch 2012. Leopoldina (R. 3). Stuttgart: Deutsche Akademie der Naturforscher Leopoldina, 414-422.

Rechsteiner, Markus; Zimmermann, Anne-Katrin; Wild, Peter J; Caduff, Rosmarie; von Teichman, Adriana; Fink, Daniel; Moch, Holger; Noske, Aurelia (2013). TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type. Experimental and Molecular Pathology, 95(2):235-241.

Srigley, John R; Delahunt, Brett; Eble, John N; Egevad, Lars; Epstein, Jonathan I; Grignon, David; Hes, Ondrej; Moch, Holger; Montironi, Rodolfo; Tickoo, Satish K; Zhou, Ming; Argani, Pedram (2013). The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. American Journal of Surgical Pathology, 37(10):1469-1489.

Delahunt, Brett; Cheville, John C; Martignoni, Guido; Humphrey, Peter A; Magi-Galluzzi, Cristina; McKenney, Jesse; Egevad, Lars; Algaba, Ferran; Moch, Holger; Grignon, David J; Montironi, Rodolfo; Srigley, John R (2013). The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. American Journal of Surgical Pathology, 37(10):1490-1504.

Casagrande, Silvia; Ruf, Melanie; Rechsteiner, Markus; Morra, Laura; Brun-Schmid, Sonja; von Teichman, Adriana; Krek, Wilhelm; Schraml, Peter; Moch, Holger (2013). The Protein-Tyrosine Phosphatase Receptor Type J is regulated by the pVHL-HIF axis in Clear Cell Renal Cell Carcinoma. Journal of Pathology, 229(4):525-534.

Teleki, Ivett; Krenacs, Tibor; Szasz, Marcell A; Kulka, Janina; Wichmann, Barna; Leo, Cornelia; Papassotiropoulos, Barbel; Riemenschnitter, Cosima; Moch, Holger; Varga, Zsuzsanna (2013). The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer. BMC Cancer, 13(1):50.

Tag, Brigitte; Mausbach, Julian; Moch, Holger (2013). Thematische Einführung. In: Tag, Brigitte; et al. Autopsie und Religion: Die Sektion aus medizinischer, ethischer und religiöser Sicht. Weimar: VDG - Verlag und Datenbank fuer Geisteswissenschaften, 9-13.

Storz, Martina; Moch, Holger (2013). Tissue microarrays and biomarker validation in molecular diagnostics. In: Cheng, Liang; Zhang, David Y; Eble, John N. Molecular Genetic Pathology. New York: Springer, 455-461.

Dannenmann, Stefanie Regine; Thielicke, Julia; Stöckli, Martina; Matter, Claudia; von Boehmer, Lotta; Cecconi, Virginia; Hermanns, Thomas; Hefermehl, Lukas; Schraml, Peter; Moch, Holger; Knuth, Alexander; van den Broek, Maries (2013). Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma. OncoImmunology, 2(3):e23562.

Rössle, Matthias; Sigg, Michèle; Rüschoff, Jan H; Wild, Peter J; Moch, Holger; Weber, Achim; Rechsteiner, Markus P (2013). Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF (V600E) mutations in colorectal carcinoma. Virchows Archiv, 463(5):623-631.

Moch, Holger; Rössle, Matthias (2013). Von der personalisierten Diagnostik zur individualisierten Therapie. In: Marti, Rolf. Krebsforschung in der Schweiz. Bern: Krebsliga Schweiz, 61-64.

Der Pathologe : Verhandlungen 2012 der Deutschen Gesellschaft für Pathologie e.V. Edited by: Moch, Holger (2012). Berlin: Springer-Verlag.

Pathologie. Edited by: Böcker, Werner; Denk, Helmut; Heitz, Philipp; Moch, Holger; Höfler, Gerald; Kreipe, Hans (2012). München: Elsevier.

Moch, Holger; Zimmermann, Dieter R; Probst-Hensch, Nicole (2012). Pathologie: Aufgaben und Methoden. In: Böcker, W; Denk, H; Heitz, P U; Höfler, G; Kreipe, H; Moch, H. Pathologie. München: Elsevier, Urban & Fischer, 3-19.

Boysen, Gunther; Bausch-Fluck, Damaris; Thoma, Claudio R; Nowicka, Anna M; Stiehl, Daniel P; Cima, Igor; Van-Duc, Luu; von Teichman, Adriana; Hermanns, Thomas; Sulser, Tullio; Ingold-Heppner, Barbara; Fankhauser, Niklaus; Wenger, Roland H; Krek, Wilhelm; Schraml, Peter; Wollscheid, Bernd; Moch, Holger (2012). Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinoma. Neoplasia, 14(6):535-546.

Meyer, Stefanie; Fuchs, Thomas J; Bosserhoff, Anja K; Hofstädter, Ferdinand; Pauer, Armin; Roth, Volker; Buhmann, Joachim M; Moll, Ingrid; Anagnostou, Nikos; Brandner, Johanna M; Ikenberg, Kristian; Moch, Holger; Landthaler, Michael; Vogt, Thomas; Wild, Peter J (2012). A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS ONE, 7(6):e38222.

Moch, Holger (2012). An overview of renal cell cancer: Pathology and genetics. Seminars in Cancer Biology, 23(1):3-9.

Lehr, Hans-Anton; Moch, Holger; Christen, Brigitte; Safret, Alexandra; Gugger, Mathias; Rössle, Matthias; von Gunten, Michael; Lemoine, Robert; Kurt, Ann-Marie; Caduff, Rosmarie; Walter, Arnold; Singer, Gad; Luscieti, Peter; Bannwart, Fridolin; Genton, Claude Y (2012). Board examination for anatomical pathology in Switzerland: two intense days to verify professional competence. Virchows Archiv, 461(1):87-92.

Gupta, Ruta; Billis, Athanase; Shah, Rajal B; Moch, Holger; Osunkoya, Adeboye O; Jochum, Wolfram; Hes, Ondrej; Bacchi, Carlos E; de Castro, Marilia G; Hansel, Donna E; Zhou, Ming; Vankalakunti, Mahesha; Salles, Paulo G; Cabrera, Rafael A; Gown, Allen M; Amin, Mahul B (2012). Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship. American Journal of Surgical Pathology, 36(9):1265-1278.

Schoenewolf, Nicola L; Dummer, Reinhard; Mihic-Probst, Daniela; Moch, Holger; Simcock, Mathew; Ochsenbein, Adrian; Gillessen, Silke; Schraml, Peter; von Moos, Roger (2012). Detecting BRAF mutations in formalin-fixed melanoma: experiences with two state-of-the-art techniques. Case Reports in Oncology, 5(2):280-289.

Schwanda-Burger, Stefanie; Moch, Holger; Muntwyler, Jörg; Salomon, Franco (2012). Diagnostic errors in the new millennium: a follow-up autopsy study. Modern Pathology, 25(6):777-783.

Thunnissen, Erik; Bubendorf, Lukas; Dietel, Manfred; Elmberger, Göran; Kerr, Keith; Lopez-Rios, Fernando; Moch, Holger; Olszewski, Wlodzimierz; Pauwels, Patrick; Penault-Llorca, Frédérique; Rossi, Giulio (2012). EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations. Virchows Archiv, 461(3):245-257.

Wolf, Monika Julia; Hoos, Alexandra; Bauer, Judith; Boettcher, Steffen; Knust, Markus; Weber, Achim; Simonavicius, Nicole; Schneider, Christoph; Lang, Matthias; Stürzl, Michael; Croner, Roland S; Konrad, Andreas; Manz, Markus G; Moch, Holger; Aguzzi, Adriano; van Loo, Geert; Pasparakis, Manolis; Prinz, Marco; Borsig, Lubor; Heikenwalder, Mathias (2012). Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell, 22(1):91-105.

Zhou, Weibin; Otto, Edgar A; Cluckey, Andrew; Airik, Rannar; Hurd, Toby W; Chaki, Moumita; Diaz, Katrina; Lach, Francis P; Bennett, Geoffrey R; Gee, Heon Yung; Ghosh, Amiya K; Natarajan, Sivakumar; Thongthip, Supawat; Veturi, Uma; Allen, Susan J; Janssen, Sabine; Ramaswami, Gokul; Dixon, Joanne; Burkhalter, Felix; Spoendlin, Martin; Moch, Holger; Mihatsch, Michael J; Verine, Jerome; Reade, Richard; Soliman, Hany; Godin, Michel; Kiss, Denes; Monga, Guido; Mazzucco, Gianna; Amann, Kerstin; Artunc, Ferruh; Newland, Ronald C; Wiech, Thorsten; Zschiedrich, Stefan; Huber, Tobias B; Friedl, Andreas; Slaats, Gisela G; Joles, Jaap A; Goldschmeding, Roel; Washburn, Joseph; Giles, Rachel H; Levy, Shawn; Smogorzewska, Agata; Hildebrandt, Friedhelm (2012). FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nature Genetics, 44(8):910-915.

Walter, Bernhard; Hartmann, Arndt; Hofstädter, Ferdinand; Junker, Kerstin; Moch, Holger; Bertz, S; Denzinger, Stefan; Otto, Wolfgang; Gajda, Mieczyslaw; Stoehr, C G (2012). Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria. Virchows Archiv, 460(3):343-352.

Peifer, Martin; Fernández-Cuesta, Lynnette; Sos, Martin L; et al; Soltermann, Alex; Moch, Holger (2012). Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nature Genetics, 44(10):1104-1110.

Beleut, Manfred; Zimmermann, Philip; Baudis, Michael; Bruni, Nicole; Bühlmann, Peter; Laule, Oliver; Luu, Van-Duc; Gruissem, Wilhelm; Schraml, Peter; Moch, Holger (2012). Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome. BMC Cancer, 12:310.

Fritzsche, Florian Rudolf; Ramach, Constanze; Soldini, Davide; Caduff, Rosmarie; Tinguely, Marianne; Cassoly, Estelle; Moch, Holger; Stewart, Antony (2012). Occupational health risks of pathologists - results from a nationwide online questionnaire in Switzerland. BMC Public Health, 12:1054.

Dettmer, Matthias; Schmitt, Anja; Steinert, Hans; Moch, Holger; Komminoth, Paul; Perren, Aurel (2012). Poorly differentiated oncocytic thyroid carcinoma - diagnostic implications and outcome. Histopathology, 60(7):1045-1051.

Gerstung, Moritz; Beisel, Christian; Rechsteiner, Markus; Wild, Peter; Schraml, Peter; Moch, Holger; Beerenwinkel, Niko (2012). Reliable detection of subclonal single-nucleotide variants in tumour cell populations. Nature Communications, 3:811.

Wulf, Marie-Angela; Bode, Beata; Zimmermann, Dieter; Rufibach, Kaspar; Weder, Walter; Moch, Holger; Soltermann, Alex; Tischler, Verena (2012). Silver-enhanced In Situ Hybridization for Determination of EGFR Copy Number Alterations in Non-Small Cell Lung Cancer. The American journal of surgical pathology, 36(12):1801-1808.

Shakhova, Olga; Zingg, Daniel; Schaefer, Simon M; Hari, Lisette; Civenni, Gianluca; Blunschi, Jacqueline; Claudinot, Stéphanie; Okoniewski, Michal; Beermann, Friedrich; Mihic-Probst, Daniela; Moch, Holger; Wegner, Michael; Dummer, Reinhard; Barrandon, Yann; Cinelli, Paolo; Sommer, Lukas (2012). Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nature Cell Biology, 14(8):882-890.

Mihic-Probst, Daniela; Ikenberg, Kristian; Tinguely, Marianne; Schraml, Peter; Behnke, Silvia; Seifert, Burkhardt; Civenni, Gianluca; Sommer, Lukas; Moch, Holger; Dummer, Reinhard (2012). Tumor cell plasticity and angiogenesis in human melanomas. PLoS ONE, 7(3):e33571.

von Teichman, Adriana; Storz, Martina; Dettwiler, Susanne; Moch, Holger; Schraml, Peter (2012). Whole genome and transcriptome amplification: practicable tools for sustainable tissue biobanking? Virchows Archiv, 461(5):571-580.

Wild, Peter J; Ikenberg, Kristian; Fuchs, Thomas J; Rechsteiner, Markus; Georgiev, Strahil; Fankhauser, Niklaus; Noske, Aurelia; Roessle, Matthias; Caduff, Rosmarie; Dellas, Athanassios; Fink, Daniel; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2012). p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Molecular Medicine, 4(8):808-824.

Curioni-Fontecedro, Alessandra; Nuber, Natko; Mihic-Probst, Daniela; Seifert, Burkhardt; Soldini, Davide; Dummer, Reinhard; Knuth, Alexander; van den Broek, Maries; Moch, Holger (2011). Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients. PLoS ONE, 6(6):e21418.

Civenni, Gianluca; Walter, Anne; Kobert, Nikita; Mihic-Probst, Daniela; Zipser, Marie; Belloni, Benedetta; Seifert, Burkhardt; Moch, Holger; Dummer, Reinhard; van den Broek, Maries; Sommer, Lukas (2011). Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Research, 71(8):3098-3109.

von Boehmer, Lotta; Keller, Lukas; Mortezavi, Ashkan; Provenzano, Maurizio; Sais, Giovanni; Hermanns, Thomas; Sulser, Tullio; Jungbluth, Achim A; Old, Lloyd J; Kristiansen, Glen; van den Broek, Maries; Moch, Holger; Knuth, Alexander; Wild, Peter J (2011). MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer. PLoS ONE, 6(7):e21366.

Sharma, Anu; Bode, Beata; Wenger, Roland H; Lehmann, Kuno; Sartori, Alessandro A; Moch, Holger; Knuth, Alexander; von Boehmer, Lotta; van den Broek, Maries (2011). γ-radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo. PLoS ONE, 6(11):e28217.

Nuber, Natko; Curioni-Fontecedro, Alessandra; Matter, Claudia; Soldini, Davide; Tiercy, Jean Marie; von Boehmer, Lotta; Moch, Holger; Dummer, Reinhard; Knuth, Alexander; van den Broek, Maries (2010). Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 107(34):15187-15192.

Walter, Anne; Barysch, Marjam J; Behnke, Silvia; Dziunycz, Piotr; Schmid, Bruno; Ritter, Erika; Gnjatic, Sacha; Kristiansen, Glen; Moch, Holger; Knuth, Alexander; Dummer, Reinhard; van den Broek, Maries (2010). Cancer testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas. Clinical Cancer Research, 16(14):3562-3570.

Tischler, Verena; Fritzsche, Florian R; Gerhardt, Josefine; Jäger, Christian; Stephan, Carsten; Jung, Klaus; Dietel, Manfred; Moch, Holger; Kristiansen, Glen (2010). Comparison of the diagnostic value of fatty acid synthase (FASN) with alpha-methylacyl-CoA racemase (AMACR) as prostatic cancer tissue marker. Histopathology, 56(6):811-815.

Sconocchia, Giuseppe; Spagnoli, Giulio C; Del Principe, Domenico; Ferrone, Soldano; Anselmi, Maurizio; Wongsena, Wachanan; Cervelli, Valerio; Schultz-Thater, Elke; Wyler, Stephen; Carafa, Vincenza; Moch, Holger; Terracciano, Luigi; Tornillo, Luigi (2009). Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction. Neoplasia, 11(7):662-671.

Gutzwiller, Felix; Moch, Holger; Probst-Hensch, Nicole (2009). Geleitwort des Lenkungsausschusses des Krebsregisters des Kantons Zürich. In: Bopp, Matthias; Ebnöther, Eva; Probst-Hensch, Nicole. Krebs im Kanton Zürich : ein Bericht des Krebsregisters. Zürich: Institut für Sozial- und Präventivmedizin der Universität Zürich, V-VI.

Perner, Sven; Wagner, Patrick L; Demichelis, Francesca; Mehra, Rohit; LaFargue, Christopher J; Moss, Benjamin J; Arbogast, Stefanie; Soltermann, Alex; Weder, Walter; Giordano, Thomas J; Beer, David G; Rickman, David S; Chinnaiyan, Arul M; Moch, Holger; Rubin, Mark A (2008). EML4-ALK fusion lung cancer: a rare acquired event. Neoplasia, 10(3):298-302.

Spahn, Donat R; Moch, Holger; Hofmann, A; Isbister, J P (2008). Patient Blood Management: the pragmatic solution for the problems with blood transfusions. Anesthesiology, 109(6):951-953.

Weber, Achim; Kristiansen, Ilka; Johannsen, Manfred; Oelrich, Beibei; Scholmann, Katharina; Gunia, Sven; Mayr, Matthias; Meyer, Hellmuth-Alexander; Behnke, Silvia; Moch, Holger; Kristiansen, Glen (2008). The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer. BMC Cancer, 8:369.

Bruder, Elisabeth; Moch, Holger; Ehrlich, David; Leuschner, Ivo; Harms, Dieter; Argani, Pedram; Briner, Jakob; Graf, Norbert; Selle, Barbara; Rufle, Alex; Paulussen, Michael; Koesters, Robert (2007). Wnt signaling pathway analysis in renal cell carcinoma in young patients. Modern Pathology, 20(12):1217-1229.

Schmitt, Anja M; Anlauf, Martin; Rousson, Valentin; Schmid, Sonja; Kofler, Andreas; Riniker, Florian; Bauersfeld, Juliane; Barghorn, Andre; Probst-Hensch, Nicole M; Moch, Holger; Heitz, Philipp U; Kloeppel, Guenter; Komminoth, Paul; Perren, Aurel (2007). WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. American Journal of Surgical Pathology, 31(11):1677-1682.

Mertz, Kirsten D; Demichelis, Francesca; Kim, Robert; Schraml, Peter; Storz, Martina; Diener, Pierre-André; Moch, Holger; Rubin, Mark A (2007). Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. Human Pathology, 38(10):1454-1462.

Ziegler, Annemarie; Seemayer, Christian A; Hinterberger, Marc; Vogt, Peter; Bigosch, Colette; Gautschi, Oliver; Tornillo, Luigi; Betticher, Daniel C; Moch, Holger; Stahel, Rolf A (2007). Low prevalence of SV40 in Swiss mesothelioma patients after elimination of false-positive PCR results. Lung Cancer, 57(3):282-291.

Argani, Pedram; Olgac, Semra; Tickoo, Satish K; Goldfischer, Michael; Moch, Holger; Chan, David Y; Eble, John N; Bonsib, Stephen M; Jimeno, Mireya; Lloreta, Josep; Billis, Athanase; Hicks, Jessica; De Marzo, Angelo M; Reuter, Victor E; Ladanyi, Marc (2007). Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. American Journal of Surgical Pathology, 31(8):1149-1160.

Frigerio, Simona; Padberg, Barbara C; Strebel, Räto T; Lenggenhager, Daniela; Messthaler, Angelika; Abdou, Marie-Therese; Moch, Holger; Zimmermann, Dieter R (2007). Improved detection of bladder carcinoma cells in voided urine by standardized microsatellite analysis. International Journal of Cancer, 121(2):329-338.

Stadlmann, Sylvia; Gueth, Uwe; Baumhoer, Daniel; Moch, Holger; Terracciano, Luigi; Singer, Gad (2007). Glypican-3 expression in primary and recurrent ovarian carcinomas. International Journal of Gynecological Pathology, 26(3):341-344.

Schmid, Simone; Opravil, Milos; Moddel, Michael; Huber, Milo; Pfammatter, Rahel; Keusch, Gerald; Ambuhl, Patrice; Wuthrich, Rudolf P; Moch, Holger; Varga, Zsuzsanna (2007). Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies. Virchows Archiv, 450(6):665-670.

Tinguely, Marianne; Jenni, Bettina; Reineke, Tanja; Korol, Dimitri; Kofler, Andreas; Rousson, Valentin; Dommann-Scherrer, Corina; Maurer, Robert; Moch, Holger; Probst-Hensch, Nicole M (2007). Chromosomal translocations t(4;14), t(11;14) and proliferation rate stratify patients with mature plasma cell myelomas into groups with different survival probabilities: a molecular epidemiologic study on tissue microarrays. American Journal of Surgical Pathology, 31(5):690-696.

Thoma, Claudio R; Frew, Ian J; Hoerner, Christian R; Montani, Matteo; Moch, Holger; Krek, Wilhelm (2007). pVHL and GSK3beta are components of a primary cilium-maintenance signalling network. Nature Cell Biology, 9(5):588-595.

Giger, Olivier T; Lacoste, Elena; Honegger, Christoph; Padberg, Barbara; Moch, Holger; Varga, Zsuzsanna (2007). Expression of the breast differentiation antigen NY-BR-1 in a phyllodes tumor of the vulva. Virchows Archiv, 450(4):471-474.

Huber, Lars C; Brock, Matthias; Hemmatazad, Hossein; Giger, Olivier T; Moritz, Falk; Trenkmann, Michelle; Distler, Jörg H W; Gay, Renate E; Kolling, Christoph; Moch, Holger; Michel, Beat A; Gay, Steffen; Distler, Oliver; Jüngel, Astrid (2007). Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis & Rheumatism, 56(4):1087-1093.

Jäger, Dirk; Filonenko, Valeriy; Gout, Ivan; Frosina, Denise; Eastlake-Wade, Susannah; Castelli, Sandra; Varga, Zsuzsanna; Moch, Holger; Chen, Yao-Tseng; Busam, Klaus J; Seil, Inka; Old, Lloyd J; Nissan, Aviram; Frei, Claudia; Gure, Ali O; Knuth, Alexander; Jungbluth, Achim A (2007). NY-BR-1 is a differentiation antigen of the mammary gland. Applied Immunohistochemistry and Molecular Morphology, 15(1):77-83.

Hinterberger, Marc; Reineke, Tanja; Storz, Martina; Weder, Walter; Vogt, Peter; Moch, Holger (2007). D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation. Modern Pathology, 20(2):248-255.

Zippelius, Alfred; Gati, Asma; Bartnick, Tammo; Walton, Senta; Odermatt, Bernhard; Jaeger, Elke; Dummer, Reinhold; Urosevic, Mirjana; Filonenko, Valeriy; Osanai, Kazuhiro; Moch, Holger; Chen, Yao-Tseng; Old, Lloyd J; Knuth, Alexander; Jaeger, Dirk (2007). Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients. Cancer Immunology, Immunotherapy, 56(2):249-258.

Perren, Aurel; Wiesli, Peter; Schmid, Sonja; Montani, Matteo; Schmitt, Anja; Schmid, Christoph; Moch, Holger; Komminoth, Paul (2006). Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient. American Journal of Surgical Pathology, 30(8):1047-1051.

Reineke, Tanja; Jenni, Bettina; Abdou, Marie-Therese; Frigerio, Simona; Zubler, Petra; Moch, Holger; Tinguely, Marianne (2006). Ultrasonic decalcification offers new perspectives for rapid FISH, DNA, and RT-PCR analysis in bone marrow trephines. American Journal of Surgical Pathology, 30(7):892-896.

Varga, Zsuzsanna; Theurillat, Jean-Philippe; Filonenko, Valeriy; Sasse, Bernd; Odermatt, Bernhard; Jungbluth, Achim A; Chen, Yao-Tseng; Old, Lloyd J; Knuth, Alexander; Jäger, Dirk; Moch, Holger (2006). Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases. Clinical Cancer Research, 12(9):2745-2751.

Vogler, Susanne; Pahnke, Jens; Rousset, Sophie; Ricquier, Daniel; Moch, Holger; Miroux, Bruno; Ibrahim, Saleh M (2006). Uncoupling protein 2 has protective function during experimental autoimmune encephalomyelitis. American Journal of Pathology, 168(5):1570-1575.

Bode, Beata; Frigerio, Simona; Behnke, Silvia; Senn, Belinda; Odermatt, Bernhard; Zimmermann, Dieter R; Moch, Holger (2006). Mutations in the tyrosine kinase domain of the EGFR gene are rare in synovial sarcoma. Modern Pathology, 19(4):541-547.

Tickoo, Satish K; dePeralta-Venturina, Mariza N; Harik, Lara R; Worcester, Heath D; Salama, Mohamed E; Young, Andrew N; Moch, Holger; Amin, Mahul B (2006). Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. American Journal of Surgical Pathology, 30(2):141-153.

Lardinois, Didier; Weder, Walter; Roudas, Marina; von Schulthess, Gustav K; Tutic, Michaela; Moch, Holger; Stahel, Rolf A; Steinert, Hans C (2005). Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. Journal of Clinical Oncology, 23(28):6846-6853.

Baker, Patricia M; Moch, Holger; Oliva, Esther (2005). Unusual morphologic features of endometrial stromal tumors: a report of 2 cases. American Journal of Surgical Pathology, 29(10):1394-1398.

Mazón Peláez, Ignacio; Vogler, Susanne; Strauss, Ulf; Wernhoff, Patrik; Pahnke, Jens; Brockmann, Gudrun; Moch, Holger; Thiesen, Hans-Juergen; Rolfs, Arndt; Ibrahim, Saleh M (2005). Identification of quantitative trait loci controlling cortical motor evoked potentials in experimental autoimmune encephalomyelitis: correlation with incidence, onset and severity of disease. Human Molecular Genetics, 14(14):1977-1989.

Weber, Walter P; Zanetti, Rosanna; Langer, Igor; Dellas, Sophie; Zuber, Markus; Moch, Holger; Remmel, Eugenia; Oertli, Daniel; Wight, Edward; Marti, Walter R (2005). Mammotome: less invasive than ABBI with similar accuracy for early breast cancer detection. World Journal of Surgery, 29(4):495-499.

Langer, Igor; Marti, Walter Richard; Guller, Ulrich; Moch, Holger; Harder, Felix; Oertli, Daniel; Zuber, Markus (2005). Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Annals of Surgery, 241(1):152-158.

Went, Philip; Dirnhofer, Stephan; Salvisberg, Tiziana; Amin, Mahul B; Lim, So D; Diener, Pierre-André; Moch, Holger (2005). Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors. American Journal of Surgical Pathology, 29(1):83-88.

This list was generated on Mon Jun 24 22:18:16 2019 CEST.